Gilead says its therapy delayed growth of tumors in aggressive form of breast cancerApril 22, 2025Check out STAT+Sponsored By Justin Sullivan/Getty Images STAT+ | Gilead says its therapy delayed growth of tumors in aggressive form of breast cancer The therapy, used in combination with Keytruda, could provide a new option for women with newly diagnosed, metastatic, triple-negative breast cancer. By Adam Feuerstein U.S. Supreme Court appears likely to uphold ACA preventive care coverage mandate With two conservative justices appearing skeptical of oral arguments against the mandate on Monday, it seems likely to withstand the challenge. By Associated Press STAT+ | NIH bans all future grants to universities with DEI programs or Israel boycotts The new rules escalate the Trump administration's campaign to force universities to end DEI programs and combat antisemitism By Anil Oza Ben Curtis/AP STAT+ | NIH director calls Trump's anti-DEI orders 'misunderstood,' downplays reorganization plans Director says he "wouldn't have accepted the job" if Trump orders were meant to stop research advancing health of minority populations By Jonathan Wosen More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments